Concepedia

Volodymyr Tryndyak

VT

Statistics

Publications

87

Citations

6.6K

H-Index

44

Active since

2005

Affiliations

National Center for Toxicological Research(Current)

United States Food and Drug Administration

University of Arkansas for Medical Sciences

National Cancer Institute

University of North Carolina at Chapel Hill

Volodymyr Tryndyak is an author at National Center for Toxicological Research specializing in epigenetics, molecular biology, and liver disease.

Publications per year

2005–2023

87

Publications

87

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

Olga Kovalchuk, Jody Filkowski, James Meservy et al. · Molecular Cancer Therapeutics · 2008 · 636 citations · Full text

Medicine, Molecular Biology, Oncology +17

Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin

Igor P. Pogribny, Jody Filkowski, Volodymyr Tryndyak et al. · International Journal of Cancer · 2010 · 332 citations

Medicine, Cancer Biology, Oncology +17

Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid

Shelia Hoar Zahm, Jens Peter Bonde, Weihsueh A. Chiu et al. · The Lancet Oncology · 2023 · 327 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +14

E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells

Volodymyr Tryndyak, Frederick A. Beland, Igor P. Pogribny · International Journal of Cancer · 2009 · 222 citations

Life Sciences, Cell Biology, Oncology +17

Role of ferritin alterations in human breast cancer cells

Svitlana Shpyleva, Volodymyr Tryndyak, Olga Kovalchuk et al. · Breast Cancer Research and Treatment · 2010 · 215 citations

Medicine, Cell Biology, Oncology +12

1–5 of 87